Mylle S, Verhaeghe E, Van Coile L, Van de Maele B, Hoorens I, Brochez L
Department of Dermatology, University Hospital Ghent, Ghent, Belgium.
Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1309-1314. doi: 10.1111/jdv.17129. Epub 2021 Feb 12.
Early detection of skin cancer is still a major challenge in dermatology practice today. While surveillance programs are offered to high-risk patients, systematic total-body examination (TBE) in the general population is not cost-effective. In the past, we demonstrated that a lesion-directed screening (LDS) in the general population delivered similar detection rates to TBE and was less time-consuming.
To study whether a lesion-directed early-access consultation can optimize skin cancer detection in dermatology practice.
In this observational study, we offered an early-access consultation in patients contacting the dermatology department concerning 1 or 2 lesions of concern meeting predefined criteria.
342 persons were seen at the dermatology department after triage by phone. Skin cancer detection rate was 13.2% (4.1% for melanoma). If advised/referred by a doctor skin cancer detection rate was 23.6% (9% for melanoma). With a history of skin cancer, detection rate was 24.3% (4.3% for melanoma). In patients with no referral and a negative history of skin cancer, detection rate was 7.7% (1.7% for melanoma), which is at least triple the rates reported by population-based screening programs. In patients in whom the index lesion was benign, worry of having skin cancer had decreased significantly by the end of the consultation. Additional total-body examination in these patients had low additional detection rate (0.5%) and a high number of unnecessary excisions (number needed to excise 13).
An early-access dermatology consultation for LDS after triage by phone resulted in high overall skin cancer and melanoma detection rates. Our data indicate that performing TBE is especially useful if the index lesion is suspicious. In addition to surveillance programs in high-risk patients, LDS may be a way to optimize skin cancer detection in the general population and use available time more efficiently in daily dermatology practice.
皮肤癌的早期检测仍是当今皮肤科临床实践中的一项重大挑战。虽然为高危患者提供了监测项目,但在普通人群中进行系统性全身检查(TBE)并不具有成本效益。过去,我们证明在普通人群中进行病灶定向筛查(LDS)的检出率与TBE相似,且耗时更短。
研究病灶定向早期就诊咨询能否优化皮肤科临床实践中的皮肤癌检测。
在这项观察性研究中,我们为联系皮肤科并就1或2个符合预定标准的可疑病灶进行咨询的患者提供了早期就诊咨询。
经电话分诊后,342人前往皮肤科就诊。皮肤癌检出率为13.2%(黑色素瘤为4.1%)。如果由医生建议/转诊,皮肤癌检出率为23.6%(黑色素瘤为9%)。有皮肤癌病史者,检出率为24.3%(黑色素瘤为4.3%)。在未转诊且无皮肤癌病史的患者中,检出率为7.7%(黑色素瘤为1.7%),这至少是基于人群的筛查项目报告率的三倍。在索引病灶为良性的患者中,到咨询结束时,对患皮肤癌的担忧已显著减轻。这些患者额外的全身检查检出率低(0.5%),不必要的切除数量多(每切除1例需要检查13例)。
电话分诊后进行病灶定向早期皮肤科就诊咨询可实现较高的皮肤癌和黑色素瘤总体检出率。我们的数据表明,如果索引病灶可疑,进行TBE特别有用。除了针对高危患者的监测项目外,LDS可能是优化普通人群皮肤癌检测并在日常皮肤科实践中更有效利用可用时间的一种方法。